Kenneth N. Rosenbaum

Author

Also Known As

K N Rosenbaum, K Rosenbaum, K. N. Rosenbaum, K. Rosenbaum, K.N. Rosenbaum, KENNETH N. ROSENBAUM, Kenneth N Rosenbaum, Kenneth N. Rosenbaum, Kenneth Rosenbaum, Martin, Judith

Publications

4.2K

Citations

H-Index

120

Concepts

All Affiliations

Children's National George Washington University National Institutes of Health Johns Hopkins University National Human Genome Research Institute

About

Kenneth N. Rosenbaum is an author at Children's National specializing in medicine, pediatrics, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	23	2K
2	Engineering	5	5	194
3	Arts	2	2	131
4	Education	2	2	520
5	Health Sciences	2	2	107

Kenneth N. Rosenbaum

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta Wayne A. Cabral, Weizhong Chang, Aileen M. Barnes, Nature Genetics Bone DiseaseDevelopmental BiologyProlyl 3-Hydroxylase 1Lethal/severe Osteogenesis ImperfectaMetabolic Bone Disease	2007	477
Best Practices in Managing Transition to Adulthood for Adolescents With Congenital Heart Disease: The Transition Process and Medical and Psychosocial Issues Craig Sable, Elyse Foster, Karen Uzark, Circulation Family MedicineYoung Adult DevelopmentHeart FailurePediatric Heart DiseaseEducation	2011	448
Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844–848 Magdalena Koczkowska, Yunjia Chen, Tom Callens, The American Journal of Human Genetics	2017	203
Frontometaphyseal dysplasia: Neonatal radiographic diagnosis Ronald B. J. Glass, Kenneth N. Rosenbaum American Journal of Medical Genetics	1995	193
Dominant Mutations in KAT6A Cause Intellectual Disability with Recognizable Syndromic Features Emma Tham, Anna Lindstrand, Avni Santani, The American Journal of Human Genetics Recognizable Syndromic FeaturesDevelopmental BiologyMendelian DisorderGenetic DisorderGenetics	2015	140
Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations Jennifer J. Johnston, Julie C. Sapp, Joyce Turner, Human Mutation	2010	127
Muenke syndrome (FGFR3‐related craniosynostosis): Expansion of the phenotype and review of the literature Emily S Doherty, Felicitas Lacbawan, Donald W. Hadley, American Journal of Medical Genetics Part A PathologyFgfr3‐related CraniosynostosisPro250arg MutationMendelian DisorderBone Morphogenic Protein	2007	115
Haploinsufficiency of<i>SOX5</i>at 12p12.1 is associated with developmental delays with prominent language delay, behavior problems, and mild dysmorphic features Allen N. Lamb, Jill A. Rosenfeld, Nicholas J. Neill, Human Mutation Brain DevelopmentGeneticsLanguage DevelopmentGenomic MechanismAtypical Language Development	2012	101
Lovastatin as Treatment for Neurocognitive Deficits in Neurofibromatosis Type 1: Phase I Study Maria T. Acosta, P. Kardel, Karin S. Walsh, Pediatric Neurology NeuropsychologyPsychiatryNeurochemical BiomarkersNeurofibromatosis Type 1Neurology	2011	92
Further clinical and molecular delineation of the 15q24 microdeletion syndrome Heather C. Mefford, Jill A. Rosenfeld, Natasha Shur, Journal of Medical Genetics	2011	90

Page 1